Halmak Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-04-2024
- Paid Up Capital ₹ 0.12 M
as on 16-04-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2015
About Halmak Pharmaceuticals
- CIN/LLPIN
U24230TG1997PTC026415
- Company No.
026415
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 1997
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationNa, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Halmak Pharmaceuticals Private Limited offer?
Halmak Pharmaceuticals Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Common Disease Medicines, Antihistamines, Digestive System Drugs & Medicines, Antacid Drugs, Anti Ulcer Drugs, Digestive Drugs, Pain Relief Drugs & Pharmaceuticals, Diclofenac.
Who are the key members and board of directors at Halmak Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vankadara Srinivasulu  | Managing Director | 13-Feb-1997 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kadhthamar Shekhar | Director | 17-Dec-2014 | Current |
| Puram Ramakrishna | Director | 17-Dec-2014 | Current |
| Balasubramaniam | Director | 17-Dec-2014 | Current |
Financial Performance of Halmak Pharmaceuticals.
Halmak Pharmaceuticals Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Halmak Pharmaceuticals?
In 2015, Halmak Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Halmak Pharmaceuticals?
Unlock and access historical data on people associated with Halmak Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Halmak Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Halmak Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
